Based on 89 Wall Street analysts offering 12 month price targets to Fidelity Small Cap Value Fund holdings in the last 3 months. The average price target is $23.62 with a high forecast of $26.97 and a low forecast of $20.34. The average price target represents a 15.84% change from the last price of $20.39.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"plus_tr_sans","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"15":"$15","18":"$18","21":"$21","24":"$24","27":"$27"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":26.971,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n  <span style=\"color:#199ca5\">$26.97</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":23.62,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n  <span style=\"color:#828080\">$23.62</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":20.343,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n  <span style=\"color:#912767\">$20.34</span>\n  </div></div>","useHTML":true}}],"tickPositions":[15,18,21,24,27],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2023","6":"Nov<br/>2023","9":"Feb<br/>2024","12":"May<br/>2024","25":"May<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,19.49,20.065461538461538,20.640923076923077,21.216384615384612,21.79184615384615,22.36730769230769,22.94276923076923,23.51823076923077,24.093692307692308,24.669153846153847,25.244615384615386,25.820076923076922,26.39553846153846,{"y":26.971,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,19.49,19.807692307692307,20.125384615384615,20.443076923076923,20.76076923076923,21.07846153846154,21.396153846153844,21.713846153846156,22.03153846153846,22.34923076923077,22.666923076923077,22.984615384615385,23.302307692307693,{"y":23.62,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,19.49,19.555615384615383,19.621230769230767,19.68684615384615,19.75246153846154,19.818076923076923,19.883692307692307,19.94930769230769,20.014923076923075,20.08053846153846,20.146153846153847,20.21176923076923,20.277384615384616,{"y":20.343,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":17.81,"date":1682899200000,"info":"<div>Price: <b>$18<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":17.56,"date":1685577600000,"info":"<div>Price: <b>$18<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":18.84,"date":1688342400000,"info":"<div>Price: <b>$19<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":19.94,"date":1690848000000,"info":"<div>Price: <b>$20<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":19.53,"date":1693526400000,"info":"<div>Price: <b>$20<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":17.29,"date":1696204800000,"info":"<div>Price: <b>$17<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":16.77,"date":1698796800000,"info":"<div>Price: <b>$17<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":18.56,"date":1701388800000,"info":"<div>Price: <b>$19<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":19.72,"date":1704153600000,"info":"<div>Price: <b>$20<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":19.4,"date":1706745600000,"info":"<div>Price: <b>$19<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.11,"date":1709251200000,"info":"<div>Price: <b>$20<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.89,"date":1711929600000,"info":"<div>Price: <b>$21<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":19.49,"date":1714521600000,"info":"<div>Price: <b>$19<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$26.97

Average Price Target$23.62

Lowest Price Target$20.34

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

FCPVX Stocks With Highest Upside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

ZNTL

Zentalis Pharmaceuticals Inc

―

5 Buy

2 Hold

0 Sell

Moderate Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

GPCR

Structure Therapeutics, Inc. Sponsored ADR

―

6 Buy

0 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

COGT

Cogent Biosciences, Inc.

―

7 Buy

2 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

CLDX

Celldex Therapeutics

―

6 Buy

1 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

FFWM

First Foundation Inc

―

1 Buy

1 Hold

0 Sell

Moderate Buy

―

FCPVX Stocks With Highest Downside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

EAT

Brinker International

―

3 Buy

4 Hold

1 Sell

Hold

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

AAP

Advance Auto Parts Inc

―

1 Buy

13 Hold

1 Sell

Hold

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

SNV

Synovus Financial Corp

―

10 Buy

4 Hold

0 Sell

Moderate Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

SAIC

Science Applications International Corp.

―

1 Buy

4 Hold

1 Sell

Hold

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

NSIT

Insight Enterprises Inc.

―

1 Buy

2 Hold

0 Sell

Moderate Buy

―

FCPVX Mutual Fund FAQ

What is FCPVX’s average 12-month price target, according to analysts?

Based on analyst ratings, Fidelity Small Cap Value Fund’s 12-month average price target is $23.62.

What is FCPVX’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for FCPVX, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is FCPVX a Buy, Sell or Hold?

Fidelity Small Cap Value Fund has a conensus rating of Moderate Buy which is based on 64 buy ratings, 25 hold ratings and 0 sell ratings.

What is Fidelity Small Cap Value Fund’s price target?

The average price target for Fidelity Small Cap Value Fund is $23.62. This is based on 89 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $26.97 ,the lowest forecast is $20.34. The average price target represents N/A Increase from the current price of N/A.

What do analysts say about Fidelity Small Cap Value Fund?

Fidelity Small Cap Value Fund’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 89 Wall Streets Analysts.

How can I buy shares of FCPVX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing